NOR-LEA HOSPITAL
1. Target Overview & Investment Thesis
NOR-LEA HOSPITAL is a 25-bed community hospital in LEA, NM with $131.5M in net patient revenue and a 0.9% operating margin. The hospital serves a payer mix of 42.2% Medicare, 0.0% Medicaid, and 57.8% commercial.
Thesis: Turnaround. Our ML models identify $9.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.9% to 8.2% (+736bps).
| Net Revenue HCRIS | $131.5M |
| Current EBITDA COMPUTED | $1.2M |
| Operating Margin COMPUTED | 0.9% |
| Occupancy HCRIS | 17.5% |
| Revenue / Bed COMPUTED | $5.3M |
| Net-to-Gross HCRIS | 41.4% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
NM has 55 Medicare-certified hospitals with a median operating margin of -2.7%. The target's margin of 0.9% places it above the state median. Among 25 size-comparable peers (12-50 beds), the median margin is -10.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-50), prioritizing same-state peers. 25 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| NOR-LEA HOSPITAL (Target) | NM | 25 | $131.5M | 0.9% |
| SANTA FE MEDICAL CENTER | NM | 36 | $95.0M | -26.5% |
| GILA REGIONAL MEDICAL CENTER | NM | 25 | $83.6M | -3.6% |
| HOLY CROSS HOSPITAL | NM | 25 | $72.9M | -20.0% |
| LINCOLN COUNTY MEDICAL CENTER | NM | 25 | $66.7M | 4.1% |
| LOVELACE REGIONAL HOSPITAL-ROS | NM | 27 | $63.1M | 9.3% |
| ARTESIA GENERAL HOSPITAL | NM | 25 | $63.0M | -17.5% |
| MIMBRES MEMORIAL HOSPITAL | NM | 25 | $56.6M | 14.7% |
| LOS ALAMOS MEDICAL CENTER | NM | 47 | $54.2M | 5.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.6M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.6M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.6M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $84K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $1.2M |
| + RCM Uplift | +$9.7M |
| Pro Forma EBITDA | $10.8M |
| Current Margin | 0.9% |
| Pro Forma Margin | 8.2% |
| WC Released (1x) | $5.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $1.8M | $104.4M | 58.92x | 126.0% |
| Base (11x exit) | 10.0x | 11.0x | $1.8M | $115.4M | 65.14x | 130.6% |
| Bull Case | 9.0x | 11.0x | $1.6M | $147.9M | 92.77x | 147.4% |
| Bull (12x exit) | 9.0x | 12.0x | $1.6M | $161.8M | 101.50x | 151.9% |
| Bear Case | 11.0x | 10.0x | $1.9M | $55.4M | 28.44x | 95.3% |
| Bear (11x exit) | 11.0x | 11.0x | $1.9M | $61.6M | 31.60x | 99.5% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 17.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 25 hospitals with 12-50 beds
- Same-state prioritization (n=26)
- Comp margins: P25=-30.1% / P50=-10.8% / P75=4.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.